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Background: The aim of this study is to determine the 99th upper-reference limit (URL) for cardiac troponin
T (cTnT) in Italian apparently healthy subjects.
Methods: The reference population was selected from 5 cities: Bolzano (n = 290), Milano (CAMELIA-Study,
n = 287), Montignoso (MEHLP-Study, n = 306), Pisa (n = 182), and Reggio Calabria (MAREA-Study, n = 535).
Subjects having cardiac/systemic acute/chronic diseases were excluded. Participants to MEHLP project
underwent cardiac imaging investigation. High-sensitive cTnT was measured with Cobas-e411 (Roche
Diagnostics).
Results:We enrolled 1600 healthy subjects [54.6% males; age range 10–90 years; mean (SD): 36.4 (21.2) years],
including 34.6% aged b20 years, 54.5% between 20 and 64 years, and 10.9% over 65 years. In the youngest the
99th URL was 10.9 ng/L in males and 6.8 ng/L in females; in adults 23.2 ng/L and 10.2 ng/L; and in elderly
36.8 ng/L and 28.6 ng/L. After the exclusion of outliers the 99th URL values were signiﬁcantly decreased
(P b 0.05) in particular those of the oldest (13.8 ng/L and 14 ng/L). MEHLP participants were divided in healthy
and asymptomatic, according to known cardiovascular risk factors (HDL, LDL, glucose, C-reactive protein): the
99th URL of cTnT values of these subgroups was signiﬁcantly different (19.5 vs. 22.7, P b 0.05).
Conclusions: 99thURL of cTnT valueswas strongly affected by age, gender, selection of subjects and the statistical
evaluation of outliers.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Cardiac troponins (cTns) I and T are the marker of choice for the
detection of myocardial injury and the diagnosis of myocardial infarc-
tion, as recommended by the most recent guidelines [1,2]. In fact, the
recommended criteria for the diagnosis of AMI is the evidence of a risetriuretic peptide; cTn, cardiac
; LVM, left ventricularmass; Q1,
limit.
na, c/o Fondazione Toscana G.
39 050 3153309; fax:+39 050and/or fall of cardiac cTnI or cTnT with one or more values above the
99th percentile upper reference limit (URL), found in a clinical setting
suggestive of myocardial ischemia [3,4]. As a result, the correct and pre-
cise (10% CV) estimation of the 99th URL represents the cornerstone for
the differential diagnosis of the acute coronary syndromes. Over the
past 10 years cTn assays have been improved in analytical sensitivity
and precision thereby allowing themeasurement of cTn in healthy sub-
jects. According to Apple's scorecard for the classiﬁcation of cTn assays,
a high-sensitive assay must measure the 99th URL with 10% CV and
more than 50% of healthy subjects must have detectable cTn levels [5].
The increasing analytical sensitivity of cTn assays greatly inﬂuences
the 99th URL estimation. However the main factor that inﬂuences the
99th URL estimation is the selection of the reference population. ESC
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reference population, which should have a normal cardiac function as
assessed by imaging.
Age- and gender-dependent effects have been observed both for
cTnI [6–10] and cTnT [10–14] high-sensitive assays: cTn levels are
lower in women and increase with age in both genders, in particular a
sharp increment is observed after 65 years of age [6,12,15]. The age-
dependent increase in cTn might be related to a progressive increase
of heart failure due to the aging of myocardial tissue [16]. This suggests
that the selection of elderly people for the 99th URL estimation must be
performed very carefully.
Patient selection criteria have been shown to greatly affect both the
99th URL value and the cTn distribution in genders [17–20]. While, no
clear deﬁnition has been proposed for the selection of a reference
population for cTn 99th URL estimation, several Authors agree that
inclusion criteria should be based on data obtained from a health
questionnaire, on screening for renal function through the estimation
of glomerular ﬁltration rate measurement, and evaluation of hemody-
namic stress and ventricular dysfunction through brain natriuretic
peptide (BNP) or NT-proBNP measurement. In addition the reference
population should be split equally by sex, include both young and elder-
ly people, and be representative of the ethnicity present in the region
[17,18]. Finally, the mathematical approach, used to identify and
exclude the outliers, may also play a signiﬁcant role in the calculation
of cTn 99th URL [21,22].
The principal aim of this study was to determine the 99th URL for
high-sensitive cTnT (hs-cTnT) assay according to age and gender in
healthy subjects representative of the Italian population. Another aim
of this work is to evaluate the effect of different statistical methods to
exclude outliers from the 99th URL estimation for hs-cTnT assay.
2. Materials and methods
2.1. Study population
Samples from apparently healthy subjects were obtained from the
G. Monasterio Tuscany Foundation (Pisa, Italy), and in collaboration
with the clinical biochemical laboratory of the San Maurizio Regional
Hospital (Bolzano, Italy) and three Italian population studies (MEHLP,
CAMELIA and MAREA studies).
Brieﬂy, the MEHLP project is a screening study aimed at evaluating
the amount of cardiovascular subclinical pathology in an asymptomatic
general population. To this aim, the population N40 years from the
community of Montignoso (Massa, Italy) was enrolled (1474 people,
mean ± SD 61 ± 14 years, males 48%, left ventricular ejection fraction
58 ± 5%, cardiac mass index 118 ± 42 mg/m2). CAMELIA and MAREA
[23,24] studies are coordinated by the University of Milan (San Paolo
Hospital, Milano, Italy), the “Associazione Calabrese di Epatologia”
(Hepatology Association of Calabria, Reggio Calabria, Italy) and the
“Istituto Superiore di Sanità” (Institute of Health, Roma, Italy). The
CAMELIA (CArdiovascular risks, MEtabolic syndrome, Liver, and
Autoimmune) study is aimed to investigate interactions among liver
disease and cardiovascular risk and atherosclerosis. To this aim, 3550
individuals, aged 18–75, participated to the study. Subjects were ran-
domly enrolled by censoring lists in two towns that are representative
of the socio-economic and lifestyle characteristics of Northern Italy
(Abbiategrasso, Milan) and Southern Italy (Cittanova, Reggio Calabria).
According to the order of randomization, carotid artery echography
was performed on 1 out of 3 individuals in order tomeasure the carotid
intima–media thickness (IMT). Troponin T was measured in 484 out of
1180 participants who underwent IMT measurement and for which a
lithium heparin plasma aliquot was available.
With similar aims, the MAREA (Metabolic Alterations in Reggio
Calabria Adolescents) study has been carried in a population of adoles-
cents. A sample of 843 adolescents aged 10–14 years was randomly
selected from an updated school census list; troponin T was measuredin 537 participants for which a lithium heparin plasma aliquots was
available.
Subjects enrolled at the San Maurizio Regional Hospital (Bolzano;
Italy) answered to questionnaire about an on-going therapy, past or
present of cardiovascular diseases – including hypertension – cardio-
vascular surgeries, endocrine dysfunction, and kidney failure. Plasma
C-reactive protein and creatinine values were also registered.
Subjects enrolled in CAMELIA andMAREA studies underwent a health
investigation on lifestyle habits and medical history by questionnaires,
clinical examination, carotid ultrasonography, and laboratory tests
(serum creatinine, glucose, insulin, total cholesterol, HDL-cholesterol,
LDL-cholesterol, triglycerides, total bilirubin, aspartate-aminotransferase,
alanine-aminotransferase, gamma-glutamyltransferase, alkaline phos-
phatase, C-reactive protein, ferritin, iron, transferrin, homocysteine,
TSH, complete blood count). NT-proBNP was measured only in
MAREA participants.
Subjects recruited at the G. Monasterio Tuscany Foundation (Pisa,
Italy) and participants to the MEHLP study answered a detailed
questionnaire about lifestyle habits andmedical history, and underwent
clinical examination and laboratory tests (creatinine, glucose, insulin,
total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, biliru-
bin, aspartate-aminotransferase, alanine-aminotransferase, gamma-
glutamyltransferase, alkaline phosphatase, C-reactive protein, ferritin,
iron, transferrin, homocysteine, TSH, NT-proBNP, complete blood
count). Participants to the MEHLP Study were subjected to electrocar-
diogram (ECG) and cardiac imaging analysis (computed tomography
scan, carotid echography, echocardiography).
This study was carried out in compliance with the principles set
forth in the Declaration of Helsinki. The informed consent was obtained
from all subjects enrolled in the study; the respective local ethical com-
mittee approved all population studies.
2.2. Exclusion criteria and deﬁnitions
On the basis of all collected data, we excluded all subjects presenting
cardiac or systemic acute or chronic diseases, such as myocardial infarc-
tion, heart failure, coronary heart disease, hypertension, diabetes, kidney
disease, obesity, tumor, hepatitis, and chronic obstructive pulmonary
disease. Subjects using drugs, except for substitutive hormonal therapy,
were also excluded.
For the present investigations, hypertension was deﬁned as a systol-
ic blood pressure of 140 mm Hg or higher, a diastolic blood pressure of
90 mm Hg or higher, or the use of antihypertensive medications. Body
mass index (BMI) was calculated as the weight in kilograms divided
by the square of the height in meters (kg/m2); obesity was deﬁned
as BMI ≥ 30 kg/m2. Diabetes was deﬁned as a fasting blood glucose
level of 126 mg/dL (7 mmol/L) or greater, or the use of any hypoglyce-
mic agent. Glomerular ﬁltration rate (GFR) was calculated according to
the “modiﬁcation of diet in renal disease” (MDRD) formula for serum
creatinine assays not standardized to the IDMS reference method:
GFR = 186 × serum creatinine–1.154 × age–0.203 × 0.742 (if female)
[25]. All considered subjects were Caucasian. Renal disease was deﬁned
as GFR b 60 ml/min/1.73 m2.
2.3. Blood sampling and laboratory analysis
Blood samples were obtained from fasting participants between 8
and 9 AM; analyses were performed using standard clinical laboratory
procedures with automated analyzers. cTnT levels were evaluated in al-
iquot of lithium heparin plasma stored at−80 °C. Plasma concentra-
tions of cTnT were measured at the Fondazione Toscana G. Monasterio
using the hs-cTnT method (Ref. 05092744) with the automated Cobas
e411 platform by Roche Diagnostics; the assay was performed
according to the recommendations made by the manufacturer (Roche
Diagnostics, Germany) using the recalibrated control materials (lot
167345 and subsequent) [26]. The limit of blank (LoB) and the limit of
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respectively.2.4. Statistical analysis
All statistical analyses were performed with Stata/SE 10.1 for
Windows using parametric and nonparametric methods depending on
variable distribution. The 99th percentile was calculated as the absolute
single upper 99th percentile value (1-sided 99% reference interval) both
for the overall study samples and after the outlier removal.
The identiﬁcation of outlier was performed using both the non-
parametric and the parametric approach bymeans of the Tukey's meth-
od, applied to the original data, or using the standard deviation method
on ln-transformed data.
The Tukey's method involves the computation of the 25th (Q1) and
75th (Q3) percentiles and the interquartile range (IQR=Q3−Q1); the
exclusion limit corresponds to the sum of Q3 and 3 or 1.5 times IQR,
according to the following formula: Q3 + 3IQR or Q3 + 1.5IQR. In the
parametric method the exclusion limit has been calculated as the
mean value plus 2 or 3 standard deviations.
Mann–Whitney test was used for comparison between two sub-
groups, while comparison among subpopulation or several subgroups
were performed using Kruskall–Wallis test and Mann–Whitney test
with Bonferroni correctionwas used for post-hoc pairwise comparisons.
Non-parametric test for linear trend was used to evaluate the associa-
tion of cTnT values across age groups. Quantile regression using
10,000 bootstrap replicates was used to evaluate the association of the
99th URL with possible covariates including, age, gender, and study
subgroups. Probability values were 2 tailed and values of 0.05 were
considered signiﬁcant.3. Results
3.1. Characteristics of reference population
The study population included Caucasian subjects from ﬁve
locations representative of all Italian population, from North to South,
selected according to the criteria detailed in the Material and methods
section. The sources of clinical data for the 5 studies are summarized
in Table 1, while themain demographic characteristics of theﬁve select-
ed subpopulations are reported in Table 2.
Overall, 1600 Italian subjects were recruited including 873 men
(54.6%) and 727 women (45.4%). The mean (SD) age was 36.4 (21.2)
years (range 10–90 years): 553 (34.6%) subjects were b20 years, 872
(54.5%) between 20 and 64 years, and 175 (10.9%) were N65 years.
The MAREA study contributed mostly to the youngest part of the
study population, while the oldest subjects were mainly from the
MHELP study and the Bolzano subgroup. Themean age was statistically
different between all subgroups (P b 0.001).Table 1
Source of clinical data in the ﬁve subgroups constituting the reference population.
Source of clinical data
MAREA Questionnaire, laboratory analysis, clinical examination, carotid echography
Pisa Questionnaire, laboratory analysis, clinical examination,
CAMELIA Questionnaire, laboratory analysis, clinical examination, carotid echography
Bolzano Questionnaire, laboratory analysis (creatinine, C-reactive protein)
MHELP Questionnaire, laboratory analysis, clinical examination, TAC, carotid
echography, echocardiography
Laboratory analysis: serum creatinine, glucose, insulin, total cholesterol, HDL-
cholesterol, LDL-cholesterol, triglycerides, bilirubin, aspartate-aminotransferase, alanine-
aminotransferase, gamma-glutamyltransferase, alkaline phosphatase, C-reactive protein,
ferritin, iron, transferrin, homocysteine, TSH, and complete blood count.3.2. hs-cTnT distribution in the reference population according to gender
In the study population, hs-cTnT values as well as the ln-
transformed data showed a skewed distribution due to the high
percentage of sample under the LoB (46.9%) (Fig. 1). Median values of
hs-cTnT increased across age groups (P N 0.001 for linear trend) and
men showed higher hs-cTnT values than women in all ages (Fig. 2).
On the other hand the percentage of sampleswith cTnT levels higher
than the LoB and the LoD increased with age, being 19.3% and 4.2%,
respectively, in the youngest subjects (b20 years), 67.0% and 37.7% in
adults (20–64 years), and 90.9% and 77.7% in the oldest (≥65 years).
3.3. hs-cTnT 99th URL in the reference population and outlier calculation
The overall selected population showed a 99th URL of 20.1 ng/L
(95%CI: 17.6–22.6), this value was mainly determined by the 99th URL
of subjects older than 65 years. In fact the 99th URL signiﬁcantly
increased with age (P b 0.001) in both genders, being higher in men
than in women in each age class (Table 3).
Statistical outlier calculation was performed both with non-
parametric and parametric methods, the latter were applied on ln-
transformed data. As expected, the highest percentage of outliers was
detected, in both genders, in the subgroup of subjects older than
65 years (Table 3), regardless of the used statistical approach. After out-
lier removal, the 99th URL value of the reference population decreased,
ranging between 9.6 and 13.1 ng/L, as well as those of each age class in
both genders (Table 3). In particular the 99th URL of the subgroup
“≥65 years” is the most affected, being signiﬁcantly lower than the
value calculated in the whole population. In any case, we still observed
an increase of the 99thURL according to age in both genders (P= 0.038
for male and P b 0.001 for female; Table 3).
Non-parametric calculation of outliers was more restrictive than the
parametric ones, showing the highest percentage of removed subjects
and the lowest 99th URL values.
3.4. hs-cTnT 99th URL in the ﬁve subpopulations
The values of hs-cTnT 99th URL for each subgroup constituting the
reference population are reported in Table 4. The calculated 99th URLs
ranged between 8.1 ng/L of the MAREA study, which includes the
adolescent subjects, and 33.1 ng/L of the Bolzano subgroup, which com-
prises the oldest and less selected subjects. The observed differences
were almost all eliminated by the exclusion of outlier subjects. In fact
the resulting 99th URL ranged between 13.1 ng/L and 13.9 ng/L for the
three subgroups of adults recruited in the Pisa and Bolzano groups,
and the MEHLP study. Only for adults recruited in CAMELIA study the
99th URL was 11.8 ng/L, lower with respect to values calculated in the
other subgroups of adults (P b 0.05) and similar to the 99th URL obtain-
ed in the MAREA study (7.0 ng/L)
3.5. hs-cTnT 99th URL in the MEHLP study
Participants to the MEHLP study, as detailed in the Material and
methods section, are the most characterized subjects among the ﬁve
subpopulations considered in this study. In fact all MEHLP participants
were subjected to ECG and cardiac imaging analysis (computed tomog-
raphy scan, carotid echography, echocardiography), thus it has been
possible to exclude also subclinical cardiovascular diseases.
On the basis of laboratory data about the known risk factors for
cardiovascular and metabolic diseases we further divided the 306
normal subjects from the MEHLP study in two subgroups: 1) healthy
subjects (n = 125; 42.4% men; mean age ± SD: 56.7 ± 6.4 years); and
2) asymptomatic subjects (n = 181; 62.4% men; age 59.2 ± 7.9 years),
who showed one or more altered cardiovascular risk factors,
i.e.: low plasma HDL cholesterol (b40 mg/dL or 1.04 mmol/L for men;
b50 mg/dL or 1.30 mmol/L for women), or elevation of plasma glucose
Table 2
Demographics of the study populations.
Origin N Male n (%) Female n (%) Mean age, (years) Age range (years) b 20 years (%) 20–64 years (%) ≥65 years (%)
MAREA study 535 265 (49.5) 270 (50.5) 12.2 (0.9) 10–14 535 (100) 0 0
Pisa 182 146 (80.2) 36 (19.8) 36.0 (11.2) 19–90 1 (0.6) 178 (97.8) 3 (1.6)
CAMELIA study 287 132 (46.0) 155 (54.0) 42.2 (13.1) 19–75 8 (2.8) 262 (91.3) 17 (5.9)
Bolzano 290 164 (56.6) 126 (43.4) 52.2 (17.3) 18–86 9 (3.1) 200 (69.0) 81 (27.0)
MHELP study 306 166 (54.2) 140 (45.8) 58.5 (7.8) 43–76 0 232 (75.8) 74 (24.2)
Total 1600 873 (54.6) 727 (45.4)* 36.7 (21.4) 10–90 553 (34.6) 872 (54.5) 175 (10.9)
Age data are reported as mean (SD). *Chi Square test: male vs. female, P b 0.001.
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terol (N150 mg/dL or 3.89 mmol/L), triglycerides (N150 mg/dL or
1.70 mmol/L), and C-reactive protein (N0.3 mg/dL or 3 mg/L). The
asymptomatic subgroup showed a 99th URL similar to the healthy sub-
groups (P = 0.300, Table 5). Values were similar also after the outlier
removal (P = 0.336; Table 5).Fig. 1.Cardiac troponin T frequency distribution in the overall study population; A: natural
data, B: ln-trasformed data.Computed tomography scan allowed the estimation of the left
ventricular mass (LVM). Women showed a lower LVM in comparison
with men (mean ± SD: 143.8 ± 35.8 g/m2 vs. 178.2 ± 38.9 g/m2, re-
spectively) and a positive correlation existed between LVM and cTnT
values both in the whole group (Spearman's coefﬁcient: r = 0.181,
95%CI: 0.067–0.0290, P = 0.002) and healthy subgroup (r = 0.196,
95%CI: 0.011–0.037, P = 0.033).
4. Discussion
The current study allowed for the ﬁrst time the establishment of the
99th URL for hs-cTnT assay in a large Italian populationwhich consisted
of 1600 apparently healthy subjects.
International guidelines suggest selecting the reference population
for the calculation of the 99th URL of cTn on the basis of a health ques-
tionnaire, screening for renal function, and for ventricular dysfunction.
The reference population should include both young and elderly people,
and be representative of the ethnicity present in the region and, in addi-
tion, a sample size of at least 300 individuals per group has been recom-
mended to calculate the 99th URL with 95% statistical conﬁdence [18,
27]. To meet these criteria, recently reviewed by Sandoval and Apple
[28], we have set up a multicenter study to enroll a sufﬁcient number
of subjects to evaluate the variation of hs-cTnT values across age, in
both genders; in particular this reference population spans a wide age
range, from 10 to 90 years. To avoid inter-laboratory variability, cTnT
measures have been centralized in the laboratory of the Fondazione G.
Monasterio (Pisa, Italy).
Our reference population showed a higher 99th URL in comparison
with other studies [10–12,14], this difference is likely a consequence of
the lack of a clear guideline on what should be considered “normality”.Fig. 2.Distribution of cTnT values inmales and females according to age. The box indicates
the 25th and 75th percentiles, the black line corresponds to the median value and the
whiskers correspond to the 2.5th and 97.5th percentiles. Statistical comparison of males
vs. females: *P b 0.05, **P b 0.01, and ***P b 0.001.
Table 3
hs-cTnT 99th URL (95%CI; ng/L) calculation according to gender and age classes, with or without removing outlier subjects.
Reference population 99th URL (95%CI) after exclusion of outlier subjects, and % of removed subjects
Tukey 3-IQR Tukey 1.5-IQR Mean + 3-SD Mean + 2-SD
N 99th URL 99th URL % 99th URL % 99th URL % 99th URL %
Overall 1600 20.1 (17.6–22.6) 13.1 (12.3–13.2) 2.53 9.6 (9.3–9.8) 7.23 14.6 (13.5–16.1) 1.36 10.7 (10.2–10.8) 5.31
b20 years 553 8.3 (6.5–12.1) 7.5 (6.4–10.6) 0.18 6.8 (6.3–8.7) 0.54 7.5 (6.4–10.6) 0.18 7.0 (6.3–9.0) 0.36
20–64 years 872 19.9 (14.4–27.5) 12.4 (11.5–13.2) 1.82 9.7 (9.3–9.9) 5.69 13.3 (12.3–14.6) 1.14 10.4 (10.2–10.8) 3.53
≥65 years 175 33.7 (21.0–37.0) 13.9 (13.4–14.0) 12.83 9.8 (9.7–9.8) 34.22 17.8 (16.6–18.0) 5.88 11.2 (10.9–11.3) 27.27
Male 872 21.8 (19.8–33.9) 13.2 (12.9–13.5) 3.64 9.8 (9.6–9.8) 10.71 14.7 (13.5–16.1) 2.28 10.8 (10.4–11.1) 7.74
b20 years 270 10.9 (6.7–20.4) 9.2 (6.7–11.9) 0.37 6.9 (6.3–8.7) 1.11 9.2 (6.7–11.9) 0.37 7.6 (6.5–10.5) 0.74
20–64 years 503 23.2 (17.3–34.1) 13.1 (11.9–13.4) 2.97 9.8 (9.6–9.9) 9.31 14.5 (13.1–17.2) 1.78 11.0 (10.3–11.0) 5.74
≥65 years 99 36.8 (21.7–37.0) 13.8 (13.4–13.8) 15.53 9.8 (9.7–9.8) 43.69 16.7 (15.5–16.7) 9.71 11.3 (11.1–11.3) 35.92
Female 728 16.3 (12.4–18.0) 12.1 (10.2–13.2) 1.21 8.5 (8.3–9.3) 3.10 14.8 (12.2–17.5) 0.27 9.4 (8.5–10.4) 2.43
b20 years 283 6.8 (5.2–8.9) 6.8 (5.2–8.9) 0 6.8 (5.2–8.9) 0 6.8 (5.2–8.9) 0 6.8 (5.2–8.9) 0
20–64 years 369 10.2 (8.5–21.9) 9.6 (8.4–13.8) 0.27 8.5 (8.3–9.4) 1.07 9.6 (8.4–13.8) 0.27 8.8 (8.4–10.2) 0.53
≥65 years 76 28.6 (17.6–28.6) 14.0 (12.4–14.0) 9.52 9.8 (8.6–9.7) 22.62 18.0 (17.3–18.0) 1.19 11.2 (10.2–11.2) 19.05
N: number of subjects; %: percentage of removed subjects. Outlier calculationwas performedwith non-parametric (Tukey 3-IQR; Tukey 1.5IQR) or parametric (Mean + 3SD;Mean + 2-
SD) statistical methods, as detailed in Material and Methods section.
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enrolled subjects, and selection criteria of subjects, all elements that
inﬂuence the calculation on 99th URL.
In fact we conﬁrmed the effect of age and gender on median values
and 99th URL of circulating hs-cTnT, and we showed a marked increase
of these values over 65 years, in particular in women. Thus the different
99th URL observed in the ﬁve subpopulations of our study could reﬂect
their different compositions in terms of gender and age of enrolled
subjects.
The presence of outliers can signiﬁcantly modify the estimation of
percentile values, especially the 99th that is the most affected by the
extreme observations. Since the criteria used to enroll subjects in the
ﬁve subpopulations of this study were different, the presence of out-
liers is highly probable. The National Committee for Clinical Laborato-
ry Standards [29] recommends the use of the Dixon test, however this
test is not very sensitive in particular when there is more than one
outlier. In this study we tested the effect of both non-parametric and
parametric statistical methods, to identify and remove outliers. Due
to the deviation of hs-cTnT values from the normal distribution,
even after the ln-transformation, the non-parametric methods for
the outlier selection seemed the most appropriate. Among the latter,Table 4
hs-cTnT 99th URL (95% CI; ng/L) in the ﬁve subgroups constituting the reference popula-
tion with or without removing outlier subjects.
All Tukey 3-IQR % of removed subjects
MAREA 8.1 (6.5–13.5) 7.0 (6.3–10.8) 0.19
Pisa 20.2 (13.6–20.2) 13.1 (10.7–13.1) 2.75
CAMELIA 12.9 (10.1–34.4) 11.8 (10.1–13.6) 0.34
Bolzano 33.1 (21.2–37.0) 13.9 (13.3–14.2) 8.64
MHELP 20.5 (14.9–33.9) 13.1 (12.3–13.4) 2.60
Outlier calculation was performed with Tukey's method, as detailed in the Material and
methods section.
Table 5
Calculation of the hs-cTnT 99th URL (ng/L) in MEHLP study subgroups, with or without remov
All 99th U
Tukey
N 99th URL (95%CI) 99th U
Overall 306 20.5 (14.9–33.9) 13.1 (
Asymptomatic 181 22.7 (16.2–33.9) 13.2 (
Healthy 125 19.5 (10.7–22.0) 12.4 (
N: number of subjects; %: percentage of removed subjects by outlier calculation performed asthe exclusion limit corresponding to the sum of Q3 and 1.5 times IQR
(Tukey 1.5-IQR)was too restrictive, thuswe chose to use the exclusion
limit corresponding to the sum of Q3 and 3 times IQR (Tukey 3-IQR).
The percentage of outlier subjects is inﬂuenced both by the accuracy
of subject selections and by age, irrespective of gender. In fact the
major part of outlier subjects was found in the group over 65 years,
both in men and women, and in the subpopulation of Bolzano,
where apparently healthy people were selected only on the basis of
a questionnaire.
After outlier removal the 99th URL in the four subpopulations of
adult subjects was more homogeneous suggesting the utility of this
statistical approach to reduce the differences among the subpopula-
tions, constituting the reference population, mainly due to the different
approaches used for the selection of apparently healthy subjects.
Removal of outlier subjects did not affect either the described
difference between men and women or the association between age
and hs-cTnT values, even if the 99th URL decreased up to a value similar
to that declared by Roche Diagnostic, i.e. 14 ng/L, in male but lower in
female adults (≥20 years); the 99th URL in adolescents of both gender
was not affected by outlier removal. These data suggest that the ob-
served differences between genders and adolescents and adults depend
on physiological processes.
The observed increase of cTnT values across age runs in parallel with
the decrease of not measurable samples, which were nearly 80% in the
adolescent compared to 10% in the oldest class. It has been hypothesized
that circulating cTn levels are positively related to LVM, which is lower
in women than in men and in adolescents than in adults [30]. In fact, a
mild association between cTnI [31] or cTnT [32] and LVM has been
showed in small cohorts of patients without clinical evidence of acute
coronary syndrome. For the ﬁrst time, we showed an association
between cTnT values and LVM in a population of highly selected healthy
subjects, thus supporting the hypothesis that circulating troponin in
healthy subjects could be a marker of the physiological renewal of
cardiomyocytes [33].ing outlier subjects with non-parametric (Tukey 3-IQR; Tukey 1.5-IQR) methods.
RL (95%CI) after exclusion of outlier subjects, and % of removed subjects
3-IQR Tukey 1.5-IQR
RL (95%CI) % 99th URL (95%CI) %
12.3–13.4) 2.60 9.8 (9.3–9.8) 10.06
12.4–13.4) 3.83 9.8 (9.6–9.8) 13.11
10.2–12.4) 0.80 9.7 (8.9–9.8) 5.60
detailed in the Material and methods section.
381M. Franzini et al. / Clinica Chimica Acta 438 (2015) 376–381In conclusion, data collected in this study suggest that the hs-cTnT
99th URL is gender and age dependent; thus clinical study should be
performed to verify if a gender and age speciﬁc hs-cTnT 99th URL
might improve the sensitivity and speciﬁcity for myocardial infarction
diagnosis.
A limit of this study is the heterogeneity of the various subpopula-
tions included, which does not allow a deﬁnitive calculation of
gender and age speciﬁc 99th URL for hs-cTnT; in fact the minimum
number of highly selected reference individuals needed to appropriate-
ly determine the 99th URL for cTn has been reported to be 300 per
group, i.e. per gender, age and ethnicity group [21,28]. It is really difﬁcult
to enroll a high number of subjects with uniform procedures, the
improvement of statistical methods to remove outliers could allow the
set up ofmulticenter studies and the combination of differently selected
subjects to constitute a reference population that is able to fulﬁll the
recommended statistical power [28]. From the point of view of the
basic clinical research, the new high sensitive immunoassay will allow
deepening the meaning of cTn values in physiological conditions.
Acknowledgments
The Authors wish to thank the staff of the ACE Group for its commit-
ment to the current research and the foundation CARICAL (CAssa
RIsparmio di Calabria e Lucania) that ﬁnance the ACE group.
References
[1] Hamm CW, Bassand JP, Agewall S, et al. ESC Committee for Practice Guidelines. ESC
guidelines for the management of acute coronary syndromes in patients presenting
without persistent ST-segment elevation: the Task Force for the management of
acute coronary syndromes (ACS) in patients presenting without persistent ST-
segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;
32:2999–3054.
[2] Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Committee for Practice Guidelines
(CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart
failure 2008: the Task Force for the diagnosis and treatment of acute and chronic
heart failure 2008 of the European Society of Cardiology. Developed in collaboration
with the Heart Failure Association of the ESC (HFA) and endorsed by the European
Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933–89.
[3] Thygesen K, Mair J, Giannitsis E, et al. Study group on acute cardiac care. How to use
high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33:2252–7.
[4] Thygesen K, Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/WHF task force for
universal deﬁnition ofmyocardial infarction. third universal deﬁnition of myocardial
infarction. J Am Coll Cardiol 2012;60:1581–98.
[5] Apple FS. A new season for cardiac troponin assay: it's time to keep a scorecard. Clin
Chem 2009;55:1303–6.
[6] Clerico A, Fortunato A, Ripoli A, et al. Distribution of plasma cardiac troponin I values
in healthy subjects: pathophysiological considerations. Clin Chem LabMed 2008;46:
804–8.
[7] Eggers KM, Jaffe AS, Lind L, et al. Value of cardiac troponin I cutoff concentrations
below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85–92.
[8] Aw TC, Phua SK, Tan SP. Measurement of cardiac troponin I in serum with a new
high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender.
Clin Chim Acta 2013;422:26–8.
[9] Eggers KM, Lind L, Venge P, Lindahl B. Factors inﬂuencing the 99th percentile of
cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years
of age. Clin Chem 2013;59:1068–73.[10] Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay
99th percentile values from a common presumably healthy population. Clin Chem
2012;58:1574–81.
[11] Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner
sera assessed by highly sensitive cardiac troponin T and commercial cardiac tropo-
nin T and I assays. Clin Chem 2009;55:101–8.
[12] Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity
cardiac troponin T assay. Clin Chem 2010;56:254–61.
[13] Hammarsten O, FuML, Sigurjonsdottir R, et al. Troponin T percentiles from a random
population sample, emergency room patients and patients with myocardial infarc-
tion. Clin Chem 2012;58:628–37.
[14] Saenger AK, Beyrau R, Braun S, et al. Multicenter analytical evaluation of a high-
sensitivity troponin T assay. Clin Chim Acta 2011;412:748–54.
[15] Olivieri F, Galeazzi R, Giavarina D, et al. Aged-related increase of high sensitive
Troponin T and its implication in acute myocardial infarction diagnosis of elderly
patients. Mech Ageing Dev 2012;133:300–5.
[16] Pugh KG, Wei JY. Clinical implications of physiological changes in the aging heart.
Drugs Aging 2001;18:263–76.
[17] Collinson PO, Heung YM, Gaze D, et al. Inﬂuence of population selection on the 99th
percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219–25.
[18] Apple FS, Collinson PO. IFCC task force on clinical applications of cardiac biomarkers.
Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem
2012;58:54–61.
[19] Menacer S, Claessens YE, Meune C, et al. Reference range values of troponin mea-
sured by sensitive assays in elderly patients without any cardiac signs/symptoms.
Clin Chim Acta 2013;417:45–7.
[20] Koerbin G, Abhayaratna WP, Potter JM, et al. Effect of population selection on 99th
percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem
2013;46:1636–43.
[21] Hickman PE, Badrick T, Wilson SR, McGill D. Reporting of cardiac troponin —
problems with the 99th population percentile. Clin Chim Acta 2007;38:182–3.
[22] Ceriotti F, Hinzmann R, PanteghiniM. Reference intervals: theway forward. Ann Clin
Biochem 2009;46:8–17.
[23] Caserta CA, Pendino GM, Alicante S, et al. MAREA study group. Body mass index,
cardiovascular risk factors, and carotid intima-media thickness in a pediatric
population in southern Italy. J Pediatr Gastroenterol Nutr 2010;51:216–20.
[24] Caserta CA, Pendino GM, Amante A, et al. Cardiovascular risk factors, nonalcoholic
fatty liver disease, and carotid artery intima–media thickness in an adolescent
population in southern Italy. Am J Epidemiol 2010;171:1195–202.
[25] Levey AS, Coresh J, Greene T, et al. Chronic kidney disease epidemiology collabora-
tion. Expressing the Modiﬁcation of Diet in Renal Disease Study equation for
estimating glomerular ﬁltration rate with standardized serum creatinine values.
Clin Chem 2007;53:766–72.
[26] Franzini M, Masotti S, Prontera C, et al. Clinical implications of a recent adjustment to
the high-sensitivity cardiac troponin T assay: some results. Clin Chem Lab Med
2014;52:e21–3.
[27] Thygesen K, Mair J, Katus H, et al. Study Group on biomarkers in cardiology of the
ESC working group on acute cardiac care. Recommendations for the use of cardiac
troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197–204.
[28] Sandoval Y, Apple FS. The global need to deﬁne normality: the 99th percentile value
of cardiac troponin. Clin Chem 2013;60:455–62.
[29] CLSI. Deﬁning, establishing, and verifying reference intervals in the clinical laborato-
ry; approved guideline. CLSI document C28–A33rd ed. . Wayne (PA): CLSI; 2008.
[30] Cain PA, Ahl R, Hedstrom E, et al. Age and gender speciﬁc normal values of left
ventricular mass, volume and function for gradient echo magnetic resonance
imaging: a cross sectional study. BMC Med Imaging 2009;9:2.
[31] Hamwi SM, Sharma AK, Weissman NJ, et al. Troponin-I elevation in patients with
increased left ventricular mass. Am J Cardiol 2003;92:88–90.
[32] Duman D, Tokay S, Toprak A, et al. Elevated cardiac troponin T is associated with in-
creased left ventricular mass index and predicts mortality in continuous ambulatory
peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:962–7.
[33] MollovaM, Bersell K,Walsh S, et al. Cardiomyocyte proliferation contributes to heart
growth in young humans. Proc Natl Acad Sci U S A 2013;110:1446–51.
